Bio Summary:
Dr. Jim C. Hu, M.D., M.P.H., is a distinguished urologist based in New York City. With a strong commitment to advancing scientific discovery and patient care, Dr. Hu has made significant contributions to the field of urology. His impressive career spans prestigious academic institutions, groundbreaking research, and leadership roles in major medical organizations.
Education:
B.A. Economics, Johns Hopkins University (1993)
M.P.H. Health Policy and Management, Johns Hopkins School of Hygiene and Public Health (1998)
M.D., Baylor College of Medicine (1998)
Research Focus:
Dr. Hu’s research focuses on urologic oncology, with a particular emphasis on prostate cancer. He has led several multi-million dollar research projects, including PCORI awards and NCI R0-1 grants. His work has influenced national prostate cancer screening guidelines, and he continues to explore innovative approaches to improve surgical techniques and outcomes.
Professional Journey:
Dr. Hu’s career includes academic positions at Harvard Medical School, David Geffen School of Medicine at UCLA, and Weill Cornell Medical College.
He has held various roles, progressing from Instructor to Professor with Tenure.
Dr. Hu has been an attending physician at renowned medical centers, such as Brigham and Women’s Hospital, Ronald Reagan UCLA Medical Center, and Weill Cornell Medical College New York Presbyterian Hospital.
Honors & Awards:
Dr. Hu has received numerous honors, including the Clinical Innovation Award from Brigham and Women’s Physicians Organization and the Ronald P. Lynch Chair in Urologic Oncology.
Recognized as a Top Doctor by US News and World Report and Castle Connolly.
Awarded for best posters at major conferences, including the American Urological Association and European Urological Association.
Publications Top Noted & Contributions:
Dr. Hu has made significant contributions to the literature, with a high H-index of 70.
His research findings, particularly in the Prostate, Lung, Colorectal, and Ovarian screening trial, have influenced changes in national prostate cancer screening guidelines.
Dr. Hu has played a pivotal role in international publications and videos demonstrating improvements in surgical techniques.
Title: Robot-Assisted Surgery and Racial and Ethnic Disparities in Post-Prostatectomy Outcomes Among Prostate Cancer Patients
Authors: Mao, J., Genkinger, J.M., Rundle, A.G., …, Hu, J.C., Tehranifar, P.
Journal: Annals of Surgical Oncology (2024, 31(2), pp. 1373–1383)
Citations: 0
Summary: Investigates the impact of robot-assisted surgery on post-prostatectomy outcomes, with a focus on racial and ethnic disparities among prostate cancer patients.
Title: Same-Day Discharge vs Inpatient Robotic-Assisted Radical Prostatectomy: Complications, Time-Driven Activity-Based Costing, and Patient Satisfaction
Authors: Cheng, E., Gereta, S., Zhang, T.R., …, Hu, J.C., Laviana, A.A.
Journal: Journal of Urology (2023, 210(6), pp. 856–864)
Citations: 0
Summary: Explores the comparison between same-day discharge and inpatient robotic-assisted radical prostatectomy, considering complications, cost analysis, and patient satisfaction.
Title: Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)
Authors: Marciscano, A.E., Wolfe, S., Zhou, X.K., …, Hu, J.C., Nagar, H.
Journal: BMC Cancer (2023, 23(1), 781)
Citations: 1
Summary: Presents findings from a randomized phase II trial comparing the effectiveness of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks.
Title: Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
Authors: Yun, H., Kim, J., Gandhe, A., …, Hu, J.C., Schackman, B.R., Jalali, A.
Journal: JAMA network open (2023, 6(11), pp. e2344856)
Citations: 0
Summary: Analyzes the cost-effectiveness of annual prostate MRI and potential MRI-guided biopsy following prostate-specific antigen test results.
Title: Guiding Clinical Decision Making for Surgical Incontinence Treatment After Prostatectomy: A Review of the Literature
Authors: Davuluri, M., DeMeo, G., Penukonda, S., Zahid, B., Hu, J.C.
Journal: Current Urology Reports (2023, 24(11), pp. 527–532)
Citations: 0
Summary: Reviews literature to guide clinical decision-making for surgical incontinence treatment after prostatectomy.
Author Metrics:
Citations: Dr. Jim C. Hu’s research has been cited 15,172 times, reflecting the impact and influence of his work within the academic community.
Documents: He has authored 405 documents, including research articles, reviews, and other scholarly contributions.
h-index: With an h-index of 59, Dr. Hu has a substantial and consistent record of publications that have each been cited at least 59 times.
Research Timeline:
Early research focused on urologic oncology during post-doctoral training.
Established collaborative research programs at Brigham and Women’s Hospital and UCLA.
Led groundbreaking studies influencing national guidelines and receiving prestigious awards.
Ongoing research initiatives, including improving nerve-sparing techniques through computer vision.
This bio summary highlights Dr. Jim C. Hu’s academic achievements, impactful research, leadership roles, and recognition in the field of urology.
